Last updated: April 12, 2023
Sponsor: Assistance Publique Hopitaux De Marseille
Overall Status: Completed
Phase
2/3
Condition
N/ATreatment
N/AClinical Study ID
NCT02288832
2014-001559-22
RCAPHM14_0085
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women over 18 years with a pregnancy before 20 weeks are some parity and gravidity;
- Woman who understood the process and the objectives of the study and who agreed tosign an informed consent;
- Without a history of premature birth or late abortion (population at low risk ofpreterm birth);
- Having no major risk factors for prematurity: insulin-dependent diabetes, systemiclupus erythematosus, hypertension, uterine malformation, cone biopsy, multiplepregnancy;
- No pre-existing hypertension;
- Asymptomatic or symptomatic regarding the diagnosis of bacterial vaginosis.
Exclusion
Exclusion Criteria:
- Woman withdrawing her consent during the study
Study Design
Total Participants: 6800
Study Start date:
March 06, 2015
Estimated Completion Date:
October 21, 2022
Study Description
Connect with a study center
Assistance Publique Hopitaux de Marseille
Marseille, 13354
FranceSite Not Available
Hôpital Nord Assistance Publique Hôpitaux de Marseille
Marseille, 13915
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.